MaxCyte Amends Cell Loading Technology License Agreement With Medinet
Reportedly, the original 2007 Agreement had provided MaxCyte’s cell loading system for use in Medinet’s Dendritic Cell (DC) Vaccine Therapy in Japan. Medinet is currently marketing its DC
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.